Race Oncology Limited (RAC.AX)
AUD 1.0
(2.04%)
AUD 1.0
(2.04%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -13.81 Million AUD | -39.26% |
| 2023 | -9.92 Million AUD | 11.41% |
| 2022 | -11.2 Million AUD | -76.68% |
| 2021 | -6.34 Million AUD | -64.86% |
| 2020 | -3.84 Million AUD | -5.1% |
| 2019 | -3.65 Million AUD | 41.97% |
| 2018 | -6.3 Million AUD | -51.18% |
| 2017 | -4.17 Million AUD | -1212.26% |
| 2016 | -317.89 Thousand AUD | -264.27% |
| 2015 | -87.26 Thousand AUD | 5.52% |
| 2014 | -92.37 Thousand AUD | -810.34% |
| 2013 | -10.14 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -5.66 Million AUD | 0.0% |
| 2024 Q4 | -8.15 Million AUD | 0.0% |
| 2024 FY | -13.81 Million AUD | -39.26% |
| 2023 Q2 | -4.41 Million AUD | 0.0% |
| 2023 FY | -9.92 Million AUD | 11.41% |
| 2023 Q4 | -5.51 Million AUD | 0.0% |
| 2022 Q4 | -6.38 Million AUD | 0.0% |
| 2022 Q2 | -4.82 Million AUD | 0.0% |
| 2022 FY | -11.2 Million AUD | -76.68% |
| 2021 Q2 | -2.05 Million AUD | 0.0% |
| 2021 Q4 | -4.28 Million AUD | 0.0% |
| 2021 FY | -6.34 Million AUD | -64.86% |
| 2020 Q4 | -2.34 Million AUD | 0.0% |
| 2020 FY | -3.84 Million AUD | -5.1% |
| 2020 Q2 | -1.5 Million AUD | 0.0% |
| 2019 FY | -3.65 Million AUD | 41.97% |
| 2019 Q4 | -1.63 Million AUD | 0.0% |
| 2019 Q2 | -2.02 Million AUD | 0.0% |
| 2018 Q2 | -3.48 Million AUD | 0.0% |
| 2018 Q4 | -2.81 Million AUD | 0.0% |
| 2018 FY | -6.3 Million AUD | -51.18% |
| 2017 Q2 | -2.08 Million AUD | 0.0% |
| 2017 FY | -4.17 Million AUD | -1212.26% |
| 2017 Q4 | -2.09 Million AUD | 0.0% |
| 2016 Q2 | -200.12 Thousand AUD | 0.0% |
| 2016 FY | -317.89 Thousand AUD | -264.27% |
| 2016 Q4 | -117.76 Thousand AUD | 0.0% |
| 2015 Q3 | - AUD | 100.0% |
| 2015 Q1 | -3233.00 AUD | 0.0% |
| 2015 Q4 | -80.8 Thousand AUD | 0.0% |
| 2015 Q2 | -6466.00 AUD | -100.0% |
| 2015 FY | -87.26 Thousand AUD | 5.52% |
| 2014 FY | -92.37 Thousand AUD | -810.34% |
| 2013 FY | -10.14 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AdAlta Limited | -5.38 Million AUD | -156.804% |
| Acrux Limited | -5.8 Million AUD | -138.264% |
| Biome Australia Limited | -1.67 Million AUD | -727.405% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | 0.363% |
| BTC Health Limited | 1.05 Million AUD | 1409.533% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | -10.291% |
| CSL Limited | 2.64 Billion AUD | 100.523% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 67.349% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 138.779% |
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 298.426% |
| Hexima Limited | -933.87 Thousand AUD | -1379.788% |
| Immutep Limited | -39.89 Million AUD | 65.362% |
| Memphasys Limited | -4.44 Million AUD | -211.105% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 108.798% |
| Noxopharm Limited | -3.57 Million AUD | -286.218% |
| Prescient Therapeutics Limited | -8.23 Million AUD | -67.75% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 71.179% |
| Starpharma Holdings Limited | -8.16 Million AUD | -69.251% |
| Tissue Repair Ltd | -4.13 Million AUD | -233.953% |
| Biotron Limited | -3.43 Million AUD | -302.131% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 27.736% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -852.242% |
| Bio-Gene Technology Limited | -2.4 Million AUD | -473.612% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 62.21% |
| Patrys Limited | -3.53 Million AUD | -290.47% |
| Orthocell Limited | -7.18 Million AUD | -92.444% |
| Imugene Limited | -149.68 Million AUD | 90.767% |
| PYC Therapeutics Limited | -37.72 Million AUD | 63.369% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | -116.732% |
| Cynata Therapeutics Limited | -9.74 Million AUD | -41.814% |
| Arovella Therapeutics Limited | -8.74 Million AUD | -58.007% |
| Nanollose Limited | -1.15 Million AUD | -1094.873% |
| Invex Therapeutics Ltd | -1.64 Million AUD | -741.714% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 4362.464% |
| Amplia Therapeutics Limited | -4.5 Million AUD | -206.861% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | -382.465% |
| Nyrada Inc. | -1.38 Million AUD | -896.903% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 365.195% |
| Dimerix Limited | -17.07 Million AUD | 19.067% |
| PharmAust Limited | -9.03 Million AUD | -52.998% |
| AnteoTech Limited | -8.88 Million AUD | -55.614% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 76.439% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | 21.755% |
| Avecho Biotechnology Limited | -3.43 Million AUD | -302.127% |
| Actinogen Medical Limited | -13.04 Million AUD | -5.942% |
| Immuron Limited | -6.93 Million AUD | -99.213% |
| Argenica Therapeutics Limited | -5.47 Million AUD | -152.201% |